Mengqi Guo

1.8k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Mengqi Guo is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mengqi Guo has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mengqi Guo's work include Ginseng Biological Effects and Applications (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related Molecular Pathways (3 papers). Mengqi Guo is often cited by papers focused on Ginseng Biological Effects and Applications (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related Molecular Pathways (3 papers). Mengqi Guo collaborates with scholars based in China, United States and Taiwan. Mengqi Guo's co-authors include Hongbo Wang, Chunhong Yan, Lei Lei, Junran Zhang, Tingting Du, Han‐Fei Ding, Xiaoguang Chen, Heng Yang, Yichen Liu and Liyuan Wang and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

Mengqi Guo

31 papers receiving 1.4k citations

Hit Papers

ATF3 promotes erastin-induced ferroptosis by suppressing ... 2019 2026 2021 2023 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
    2019 611 citations Liyuan Wang, Yichen Liu et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengqi Guo China 16 885 504 472 181 165 34 1.4k
Xiaoyu Ji China 18 765 0.9× 495 1.0× 461 1.0× 199 1.1× 112 0.7× 53 1.3k
Rong Jiang China 23 778 0.9× 236 0.5× 356 0.8× 155 0.9× 195 1.2× 98 1.6k
Hao Zheng China 19 786 0.9× 375 0.7× 370 0.8× 72 0.4× 102 0.6× 46 1.2k
Chae Hwa Kwon South Korea 26 1.0k 1.2× 373 0.7× 327 0.7× 452 2.5× 179 1.1× 55 1.9k
Yi Jiang China 22 1.1k 1.2× 300 0.6× 611 1.3× 269 1.5× 115 0.7× 65 1.6k
Yi Luo China 24 895 1.0× 214 0.4× 499 1.1× 273 1.5× 174 1.1× 75 1.7k
Hiroshi Kuwata Japan 20 1.1k 1.3× 283 0.6× 387 0.8× 177 1.0× 208 1.3× 43 1.9k
Minru Liao China 12 705 0.8× 286 0.6× 318 0.7× 200 1.1× 137 0.8× 16 1.2k

Countries citing papers authored by Mengqi Guo

Since Specialization
Citations

This map shows the geographic impact of Mengqi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengqi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengqi Guo more than expected).

Fields of papers citing papers by Mengqi Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengqi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengqi Guo. The network helps show where Mengqi Guo may publish in the future.

Co-authorship network of co-authors of Mengqi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Mengqi Guo. A scholar is included among the top collaborators of Mengqi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengqi Guo. Mengqi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ji, Hongwei, Xiaofei Wang, Ching‐Hui Sia, et al.. (2025). Large language model comparisons between English and Chinese query performance for cardiovascular prevention. Communications Medicine. 5(1). 177–177. 3 indexed citations
3.
Guo, Mengqi, et al.. (2025). Exploring the role of gut microbiota in Parkinson’s disease: insights from fecal microbiota transplantation. Frontiers in Neuroscience. 19. 1574512–1574512.
4.
Guo, Mengqi, et al.. (2025). Effect of Oral Posaconazole on Venetoclax Plasma Concentration and its Efficacy in Patients with Acute Myeloid Leukemia. Recent Patents on Anti-Cancer Drug Discovery. 21(1). 47–61.
5.
Zhou, Chi, Fuhai Li, Wenzhong Zhang, et al.. (2024). TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2α/PPARγ axis. Journal of Molecular and Cellular Cardiology. 198. 45–59. 5 indexed citations
6.
Guo, Mengqi, Han Guo, Chuan Wan, et al.. (2024). A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Diabetologia. 67(4). 623–640. 7 indexed citations
7.
8.
9.
Chen, Yong, Wenjun Wang, Mengqi Guo, et al.. (2024). Macrophage‐mediated heart repair and remodeling: A promising therapeutic target for post‐myocardial infarction heart failure. Journal of Cellular Physiology. 239(11). e31372–e31372. 4 indexed citations
10.
11.
Pan, Wanying, et al.. (2022). Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. International Immunopharmacology. 104. 108497–108497. 15 indexed citations
12.
He, Jiao, Weihong Ren, Wenyan Han, et al.. (2022). Exosomal targeting and its potential clinical application. Drug Delivery and Translational Research. 12(10). 2385–2402. 123 indexed citations
13.
Wang, Zhaoyang, Mengqi Guo, Haitao Yuan, et al.. (2021). PARP1 deficiency protects against hyperglycemia-induced neointimal hyperplasia by upregulating TFPI2 activity in diabetic mice. Redox Biology. 46. 102084–102084. 12 indexed citations
14.
Wang, Liyuan, Yichen Liu, Tingting Du, et al.. (2019). ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–. Cell Death and Differentiation. 27(2). 662–675. 611 indexed citations breakdown →
15.
Liu, Debin, Mengqi Guo, Peng Zhou, Jie Xiao, & Xiaoping Ji. (2019). TSLP promote M2 macrophages polarization and cardiac healing after myocardial infarction. Biochemical and Biophysical Research Communications. 516(2). 437–444. 13 indexed citations
16.
Guo, Mengqi, et al.. (2019). Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance. European Journal of Medicinal Chemistry. 182. 111668–111668. 12 indexed citations
17.
Zhou, Peng, Mengqi Guo, Lei Wang, et al.. (2019). Ginsenoside Rb1 ameliorates CKD‐associated vascular calcification by inhibiting the Wnt/β‐catenin pathway. Journal of Cellular and Molecular Medicine. 23(10). 7088–7098. 51 indexed citations
18.
Li, Xingyao, Mengqi Guo, Lun Cai, et al.. (2019). Competitive ubiquitination activates the tumor suppressor p53. Cell Death and Differentiation. 27(6). 1807–1818. 34 indexed citations
19.
Zheng, Jing, Juan Chen, Xiaohan Zou, et al.. (2018). Saikosaponin d causes apoptotic death of cultured neocortical neurons by increasing membrane permeability and elevating intracellular Ca2+ concentration. NeuroToxicology. 70. 112–121. 21 indexed citations
20.
Ji, Xiaoping, et al.. (2016). Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Design Development and Therapy. 10. 1267–1267. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyu Ji Breakdown of academic impact, for papers by Rong Jiang Breakdown of academic impact, for papers by Hao Zheng Breakdown of academic impact, for papers by Chae Hwa Kwon Breakdown of academic impact, for papers by Yi Jiang Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by Hiroshi Kuwata Breakdown of academic impact, for papers by Minru Liao
Rankless by CCL
2026